CDCP1 and exocrine pancreatic carcinoma: CD318 overexpression has been recently correlated with poor overall survival (OS) in colon, breast, lung, renal, hepatocellular, and pancreatic carcinoma [8–14], possibly due to its role in metastasis formation via interaction with integrins and anti-apoptotic signaling via Akt [15–18].